Globus Medical Q1 net sales up 20% to $276.7M; non-GAAP EPS $0.53

GLOBUS MEDICAL INC

2023-Q1 EPS reported $0.48 revenue$276,688,000

Worldwide net sales $276.7M, up 20% YoY (21% constant currency); GAAP net income $49.1M.
GAAP diluted EPS $0.48; non-GAAP diluted EPS $0.53, up 24.7% YoY.
U.S. Spine sales up 14%; Enabling Technologies grew 91% to $25M.
Full-year 2023 guidance reaffirmed: net sales $1.1B, non-GAAP diluted EPS $2.30.
Pending merger with NuVasive received shareholder approvals from both companies.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

GLOBUS MEDICAL INC reported three-month period ended March 31, 2023 results: revenue $276.7 million, net income $49.1 million, EPS $0.48.

Period: three-month period ended March 31, 2023
Revenue: $276.7 million
Net income: $49.1 million
EPS: $0.48
Result: reported results

Exact text from the filing

· Worldwide net sales were $276.7 million , an increase of 20.0% , or 21.0% on a constant currency basis · GAAP net income for the quarter was $49.1 million · GAAP d iluted earnings per share (“ EPS ”) was $0.48

View on SEC.gov

Browse all earnings releases →

GLOBUS MEDICAL INC filing history →

Source: SEC EDGAR

accession 0001562762-23-000208

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.